Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review

dc.contributor.authorRodrigo, Gustavo Javier
dc.contributor.authorPlaza Moral, Vicente
dc.contributor.authorGarcía-Marcos, Luis
dc.contributor.authorCastro Rodríguez, José Antonio
dc.date.accessioned2022-01-10T18:24:17Z
dc.date.available2022-01-10T18:24:17Z
dc.date.issued2009
dc.fuente.origenORCID
dc.identifier.doi10.1016/j.pupt.2008.10.008
dc.identifier.issn1522-9629
dc.identifier.pubmedid19026757
dc.identifier.urihttps://www.doi.org/10.1016/j.pupt.2008.10.008
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-58749100633&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/63166
dc.information.autorucEscuela de medicina ; Castro Rodríguez, José Antonio ; 0000-0002-0708-4281 ; 113247
dc.issue.numeroNo. 1
dc.language.isoen
dc.pagina.final19
dc.pagina.inicio9
dc.provenancengjara 2022-01-10 15:24:17
dc.relation.isformatofPulmonary Pharmacology and Therapeutics, vol. 22, no. 1 (feb. 2009), pp. 9-19.
dc.revistaPulmonary Pharmacology and Therapeutics
dc.subjectAsthma
dc.subjectBronchodilators
dc.subjectFormoterol
dc.subjectInhaled corticosteroids
dc.subjectLong-acting beta agonists
dc.subjectSafety
dc.subjectSalmeterol
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherMedicina y salud
dc.titleSafety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review
dc.typeartículo
dc.volumenVol. 22
sipa.codpersvinculados113247
Files